Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3 Pt 1
pubmed:dateCreated
1984-4-20
pubmed:abstractText
Since lysophosphatides have been implicated as arrhythmogenic metabolites, modulation of their catabolism in cardiac myocytes has been characterized. Rat cardiac myocytes and mesenchymal cells grown in culture were found to contain cytosolic lysophospholipase with specific activities of 1.3 +/- 0.1 and 0.9 +/- 0.1 nmol X mg-1 X min-1, respectively. Rat myocytic lysophospholipase had a molecular mass of approximately 20,000 daltons, estimated by gel filtration chromatography. Kinetic analysis of cytosolic myocytic lysophospholipase demonstrated a Michaelis constant of 11 microM, a pH optimum of 8.0, and competitive inhibition by L-palmitoyl carnitine (inhibitory constant of 12 microM). Although lysophospholipase-transacylase activity could not be detected in rat myocyte or mesenchymal cell cultures, rabbit myocytes isolated by perfusion of isolated hearts with collagenase contained lysophospholipase-transacylase in cytosolic extracts with a specific activity of 0.2 nmol X mg-1 X min-1. These results demonstrate the presence of lysophospholipase in cardiac myocytes and suggest that the increase in long-chain acyl carnitine, which occurs during myocardial ischemia, may contribute to accumulation of lysophosphatides within cardiac myocytes.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0002-9513
pubmed:author
pubmed:issnType
Print
pubmed:volume
246
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
C266-70
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed:year
1984
pubmed:articleTitle
Cytosolic lysophospholipase in cardiac myocytes and its inhibition by L-palmitoyl carnitine.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't